Open Access

Evidence for CV event reduction with lower LDL-C.

Topic: Atherosclerosis
Sponsored by Amgen GmbH

Presentation

About the speaker

Professor Chris Packard

Glasgow (United Kingdom of Great Britain & Northern Ireland)
7 presentations
0 follower

5 more presentations in this session

Introduction - PCSK9 inhibitors: the evidence-based story.

Speaker: Professor K. Ray (London, GB)

Thumbnail

The LDL-C paradigm.

Speaker: Professor B. Ference (Cambridge, GB)

Thumbnail

Atherosclerosis regression and low LDL-C.

Speaker: Professor S. Nicholls (Melbourne, AU)

Thumbnail

Panel discussion - PCSK9 inhibitors: the evidence-based story.

Speaker: Professor K. Ray (London, GB)

Thumbnail

What questions remain unanswered?

Speaker: Professor K. Ray (London, GB)

Thumbnail

Access the full session

PCSK9 inhibitors: the evidence-based story

Speakers: Professor C. Packard, Professor K. Ray, Professor B. Ference, Professor S. Nicholls, Professor K. Ray...
Thumbnail

About the event

Image

ESC CONGRESS 2017

26 August - 30 August 2017

Sessions Presentations

This platform is supported by

logo Novo Nordisk